Assessment of COVID-19 vaccine hesitancy among people living with HIV/AIDS: a single-centered study
3
Issued Date
2023-01-01
Resource Type
eISSN
27072800
Scopus ID
2-s2.0-85150194812
Journal Title
Pan African Medical Journal One Health
Volume
10
Rights Holder(s)
SCOPUS
Bibliographic Citation
Pan African Medical Journal One Health Vol.10 (2023)
Suggested Citation
Shallangwa M.M., Musa S.S., Iwenya H.C., Manirambona E., Lucero-Prisno D.E., Tukur B.M. Assessment of COVID-19 vaccine hesitancy among people living with HIV/AIDS: a single-centered study. Pan African Medical Journal One Health Vol.10 (2023). doi:10.11604/pamj-oh.2023.10.2.37945 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/82307
Title
Assessment of COVID-19 vaccine hesitancy among people living with HIV/AIDS: a single-centered study
Other Contributor(s)
Abstract
Introduction: as the coronavirus disease 2019 (COVID-19) vaccines are distributed and administered globally, hesitancy towards the vaccine hinders the immunisation of a significant number of vulnerable populations, such as people living with HIV/AIDS. Hence, this study aims to assess COVID-19 vaccine hesitancy among people living with HIV/AIDS (PLHIV) attending clinical-outpatient follow-up at State Specialist Hospital Maiduguri (SSHM), Borno State, Nigeria. Methods: a hospital-based cross-sectional study design was conducted to assess COVID-19 vaccine hesitancy among 344 PLHIV receiving antiretroviral therapy (ART) at the United States President´s Emergency Plan for AIDS (PEPFAR) clinic in SSHM from 4th January to 25th February 2022. Data were collected using a structured and pretested interviewer-administered questionnaire. The results were presented using frequencies and percentages. The factors that are associated with COVID-19 vaccine hesitancy were identified using the Chi-square statistical test. Results: among the 344 respondents of the study, only 88 (26.6%) received the COVID-19 vaccine. Out of the 256 respondents that did not receive the vaccine, only 10.5% (27/256) are willing to be vaccinated, while the majority; 57.8% (148/256) are not willing to be vaccinated and 31.7% (81/256) of the respondents are uncertain, thus resulting in a hesitation rate of 89.45%. There was no statistically significant association between COVID-19 vaccine hesitancy and the study´s independent variables; where p-value is greater than 0.05. Conclusion: hesitancy towards COVID-19 vaccine is high among PLHIV and there is no any statistically significant association between COVID-19 vaccine hesitancy and the independent variables of the study where p-value is greater than 0.05. Hence, it is necessary to develop targeted strategies to boost vaccine uptake among this vulnerable population.